Chromogranin A expression in neoplastic cells affects tumor growth and morphogenesis in mouse models

Barbara Colombo, Flavio Curnis, Chiara Foglieni, Antonella Monno, Gianluigi Arrigoni, Angelo Corti

Research output: Contribution to journalArticle

Abstract

Chromogranin A (CgA), a secretory protein expressed by many neuroendocrine cells, has been recognized as a useful tissue and serum marker of neuroendocrine tumors. To investigate the effect of CgA secretion on neoplastic morphogenesis and progression, we have transfected mouse RMA lymphoma and TS/A adenocarcinoma cells with the cDNA encoding human CgA and selected several CgA-positive (secreting) and CgA-negative (nonsecreting) clones. In both models, the growth rate of CgA-positive clones implanted s.c. in nude mice was slower than that of CgA-negative clones. Histological analysis of each RMA tumor showed that CgA-expression was associated with multinodular growth patterns, whereas CgA-negative tumors appeared more compact and similar to wild-type RMA tumors. Moreover, CgA production was associated with increased tumor necrosis. The number of nodules in each RMA tumor correlated with the serum levels of CgA (n = 40, r = 0.537, P = 0.0004). The reduced growth rate of CgA-positive RMA and TS/A tumors was not related to reduced in vitro proliferation or to changes in cell adhesion and shape, suggesting that the mechanism is indirect and host-mediated. These results suggest that abnormal secretion of CgA by neuroendocrine neoplastic cells could affect neoplastic growth and morphogenesis.

Original languageEnglish
Pages (from-to)941-946
Number of pages6
JournalCancer Research
Volume62
Issue number3
Publication statusPublished - Feb 1 2002

Fingerprint

Chromogranin A
Morphogenesis
Growth
Neoplasms
Neuroendocrine Cells
Clone Cells
Neuroendocrine Tumors
Cell Shape
Nude Mice
Cell Adhesion
Lymphoma
Adenocarcinoma
Necrosis
Complementary DNA

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Chromogranin A expression in neoplastic cells affects tumor growth and morphogenesis in mouse models. / Colombo, Barbara; Curnis, Flavio; Foglieni, Chiara; Monno, Antonella; Arrigoni, Gianluigi; Corti, Angelo.

In: Cancer Research, Vol. 62, No. 3, 01.02.2002, p. 941-946.

Research output: Contribution to journalArticle

@article{b8c556c56ba744239ee6f7bc2a842883,
title = "Chromogranin A expression in neoplastic cells affects tumor growth and morphogenesis in mouse models",
abstract = "Chromogranin A (CgA), a secretory protein expressed by many neuroendocrine cells, has been recognized as a useful tissue and serum marker of neuroendocrine tumors. To investigate the effect of CgA secretion on neoplastic morphogenesis and progression, we have transfected mouse RMA lymphoma and TS/A adenocarcinoma cells with the cDNA encoding human CgA and selected several CgA-positive (secreting) and CgA-negative (nonsecreting) clones. In both models, the growth rate of CgA-positive clones implanted s.c. in nude mice was slower than that of CgA-negative clones. Histological analysis of each RMA tumor showed that CgA-expression was associated with multinodular growth patterns, whereas CgA-negative tumors appeared more compact and similar to wild-type RMA tumors. Moreover, CgA production was associated with increased tumor necrosis. The number of nodules in each RMA tumor correlated with the serum levels of CgA (n = 40, r = 0.537, P = 0.0004). The reduced growth rate of CgA-positive RMA and TS/A tumors was not related to reduced in vitro proliferation or to changes in cell adhesion and shape, suggesting that the mechanism is indirect and host-mediated. These results suggest that abnormal secretion of CgA by neuroendocrine neoplastic cells could affect neoplastic growth and morphogenesis.",
author = "Barbara Colombo and Flavio Curnis and Chiara Foglieni and Antonella Monno and Gianluigi Arrigoni and Angelo Corti",
year = "2002",
month = "2",
day = "1",
language = "English",
volume = "62",
pages = "941--946",
journal = "Journal of Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "3",

}

TY - JOUR

T1 - Chromogranin A expression in neoplastic cells affects tumor growth and morphogenesis in mouse models

AU - Colombo, Barbara

AU - Curnis, Flavio

AU - Foglieni, Chiara

AU - Monno, Antonella

AU - Arrigoni, Gianluigi

AU - Corti, Angelo

PY - 2002/2/1

Y1 - 2002/2/1

N2 - Chromogranin A (CgA), a secretory protein expressed by many neuroendocrine cells, has been recognized as a useful tissue and serum marker of neuroendocrine tumors. To investigate the effect of CgA secretion on neoplastic morphogenesis and progression, we have transfected mouse RMA lymphoma and TS/A adenocarcinoma cells with the cDNA encoding human CgA and selected several CgA-positive (secreting) and CgA-negative (nonsecreting) clones. In both models, the growth rate of CgA-positive clones implanted s.c. in nude mice was slower than that of CgA-negative clones. Histological analysis of each RMA tumor showed that CgA-expression was associated with multinodular growth patterns, whereas CgA-negative tumors appeared more compact and similar to wild-type RMA tumors. Moreover, CgA production was associated with increased tumor necrosis. The number of nodules in each RMA tumor correlated with the serum levels of CgA (n = 40, r = 0.537, P = 0.0004). The reduced growth rate of CgA-positive RMA and TS/A tumors was not related to reduced in vitro proliferation or to changes in cell adhesion and shape, suggesting that the mechanism is indirect and host-mediated. These results suggest that abnormal secretion of CgA by neuroendocrine neoplastic cells could affect neoplastic growth and morphogenesis.

AB - Chromogranin A (CgA), a secretory protein expressed by many neuroendocrine cells, has been recognized as a useful tissue and serum marker of neuroendocrine tumors. To investigate the effect of CgA secretion on neoplastic morphogenesis and progression, we have transfected mouse RMA lymphoma and TS/A adenocarcinoma cells with the cDNA encoding human CgA and selected several CgA-positive (secreting) and CgA-negative (nonsecreting) clones. In both models, the growth rate of CgA-positive clones implanted s.c. in nude mice was slower than that of CgA-negative clones. Histological analysis of each RMA tumor showed that CgA-expression was associated with multinodular growth patterns, whereas CgA-negative tumors appeared more compact and similar to wild-type RMA tumors. Moreover, CgA production was associated with increased tumor necrosis. The number of nodules in each RMA tumor correlated with the serum levels of CgA (n = 40, r = 0.537, P = 0.0004). The reduced growth rate of CgA-positive RMA and TS/A tumors was not related to reduced in vitro proliferation or to changes in cell adhesion and shape, suggesting that the mechanism is indirect and host-mediated. These results suggest that abnormal secretion of CgA by neuroendocrine neoplastic cells could affect neoplastic growth and morphogenesis.

UR - http://www.scopus.com/inward/record.url?scp=0036469125&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036469125&partnerID=8YFLogxK

M3 - Article

C2 - 11830555

AN - SCOPUS:0036469125

VL - 62

SP - 941

EP - 946

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0008-5472

IS - 3

ER -